|
1
|
Liu J, Fukunaga-Kalabis M, Li L and Herlyn
M: Developmental pathways activated in melanocytes and melanoma.
Arch Biochem Biophys. 563:13–21. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
De Milito A, Canese R, Marino ML, Borghi
M, Iero M, Villa A, Venturi G, Lozupone F, Iessi E, Logozzi M, et
al: pH-dependent antitumor activity of proton pump inhibitors
against human melanoma is mediated by inhibition of tumor acidity.
Int J Cancer. 127:207–219. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chiche J, Brahimi-Horn MC and Pouysségur
J: Tumour hypoxia induces a metabolic shift causing acidosis: A
common feature in cancer. J Cell Mol Med. 14:771–794. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Vaupel P, Kallinowski F and Okunieff P:
Blood flow, oxygen and nutrient supply, and metabolic
microenvironment of human tumors: A review. Cancer Res.
49:6449–6465. 1989.PubMed/NCBI
|
|
5
|
Harguindey S, Orive G, Pedraz Luis J,
Paradiso A and Reshkin SJ: The role of pH dynamics and the
Na+/H+ antiporter in the etiopathogenesis and
treatment of cancer. Two faces of the same coin-one single nature.
Biochim Biophys Acta. 1756:1–24. 2005.PubMed/NCBI
|
|
6
|
Rofstad EK: Microenvironment-induced
cancer metastasis. Int J Radiat Biol. 76:589–605. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Harris AL: Hypoxia-a key regulatory factor
in tumour growth. Nat Rev Cancer. 2:38–47. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mason SD and Joyce JA: Proteolytic
networks in cancer. Trends Cell Biol. 21:228–237. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wiedmann RM, von Schwarzenberg K,
Palamidessi A, Schreiner L, Kubisch R, Liebl J, Schempp C, Trauner
D, Vereb G, Zahler S, et al: The V-ATPase-inhibitor archazolid
abrogates tumor metastasis via inhibition of endocytic activation
of the Rho-GTPase Rac1. Cancer Res. 72:5976–5987. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fais S, De Milito A, You H and Qin W:
Targeting vacuolar H+-ATPases as a new strategy against
cancer. Cancer Res. 67:10627–10630. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chung C, Mader CC, Schmitz JC, Atladottir
J, Fitchev P, Cornwell ML, Koleske AJ, Crawford SE and Gorelick F:
The vacuolar-ATPase modulates matrix metalloproteinase isoforms in
human pancreatic cancer. Lab Invest. 91:732–743. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fortini ME and Bilder D: Endocytic
regulation of Notch signaling. Curr Opin Genet Dev. 19:323–328.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Vaccari T, Duchi S, Cortese K, Tacchetti C
and Bilder D: The vacuolar ATPase is required for physiological as
well as pathological activation of the Notch receptor. Development.
137:1825–1832. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang Z, Ma J, Zhu L and Zhao Y: Synthesis
and identification of cytotoxic diphyllin glycosides as vacuolar
H(+)-ATPase inhibitors. Eur J Med Chem. 82:466–471. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shen W, Zou X, Chen M, Liu P, Shen Y,
Huang S, Guo H and Zhang L: Effects of diphyllin as a novel
V-ATPase inhibitor on gastric adenocarcinoma. Eur J Pharmacol.
667:330–338. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Vandooren J, Geurts N, Martens E, Van den
Steen PE and Opdenakker G: Zymography methods for visualizing
hydrolytic enzymes. Nat Methods. 10:211–220. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lu X, Qin W, Li J, Tan N, Pan D, Zhang H,
Xie L, Yao G, Shu H, Yao M, et al: The growth and metastasis of
human hepatocellular carcinoma xenografts are inhibited by small
interfering RNA targeting to the subunit ATP6L of proton pump.
Cancer Res. 65:6843–6849. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sørensen MG, Henriksen K, Neutzsky-Wulff
AV, Dziegiel MH and Karsdal MA: Diphyllin, a novel and naturally
potent V-ATPase inhibitor, abrogates acidification of the
osteoclastic resorption lacunae and bone resorption. J Bone Miner
Res. 22:1640–1648. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yu W, Wang L, Wang Y, Xu X, Zou P, Gong M,
Zheng J, You J, Wang H, Mei F and Pei F: A novel tumor metastasis
suppressor gene LASS2/TMSG1 interacts with vacuolar ATPase through
its homeodomain. J Cell Biochem. 114:570–583. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Takahashi M, Tsunoda T, Seiki M, Nakamura
Y and Furukawa Y: Identification of membrane-type matrix
metalloproteinase-1 as a target of the beta-catenin/Tcf4 complex in
human colorectal cancers. Oncogene. 21:5861–5867. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ma Y, Zou F, Xiong J, Wan W, Yin L, Li X,
Bei Z, Yuan L, Meng S, Wang J and Song G: Effect of Matrine on HPAC
cell migration by down-regulating the expression of MT1-MMP via Wnt
signaling. Cancer Cell Int. 15:592015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kessenbrock K, Plaks V and Werb Z: Matrix
metalloproteinases: Regulators of the tumor microenvironment. Cell.
141:52–67. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Itoh Y and Seiki M: MT1-MMP: A potent
modifier of pericellular microenvironment. J Cell Physiol. 206:1–8.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kajita M, Itoh Y, Chiba T, Mori H, Okada
A, Kinoh H and Seiki M: Membrane-type 1 matrix metalloproteinase
cleaves CD44 and promotes cell migration. J Cell Biol. 153:893–904.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Deryugina EI, Ratnikov BI, Postnova TI,
Rozanov DV and Strongin AY: Processing of integrin alpha(v) subunit
by membrane type 1 matrix metalloproteinase stimulates migration of
breast carcinoma cells on vitronectin and enhances tyrosine
phosphorylation of focal adhesion kinase. J Biol Chem.
277:9749–9756. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sato H, Takino T and Miyamori H: Roles of
membrane-type matrix metalloproteinase-1 in tumor invasion and
metastasis. Cancer Sci. 96:212–217. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Seiki M: Membrane-type 1 matrix
metalloproteinase: A key enzyme for tumor invasion. Cancer Lett.
194:1–11. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Knopfová L, Beneš P, Pekarčíková L,
Hermanová M, Masařík M, Pernicová Z, Souček K and Smarda J: c-Myb
regulates matrix metalloproteinases 1/9, and cathepsin D:
Implications for matrix-dependent breast cancer cell invasion and
metastasis. Mol Cancer. 11:152012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yousef EM, Tahir MR, St-Pierre Y and
Gaboury LA: MMP-9 expression varies according to molecular subtypes
of breast cancer. BMC Cancer. 14:6092014. View Article : Google Scholar : PubMed/NCBI
|
